Your shopping cart is currently empty

IRF1 antagonist 1 (8003-3282) is a potent antagonist of IRF1 (interferon regulatory factor), exhibiting anti-inflammatory properties. This compound helps maintain the integrity of the blood-brain barrier and reduces cerebral edema. Additionally, IRF1 antagonist 1 can enhance neurological outcomes in mouse models of acute traumatic brain injury (TBI).
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | IRF1 antagonist 1 (8003-3282) is a potent antagonist of IRF1 (interferon regulatory factor), exhibiting anti-inflammatory properties. This compound helps maintain the integrity of the blood-brain barrier and reduces cerebral edema. Additionally, IRF1 antagonist 1 can enhance neurological outcomes in mouse models of acute traumatic brain injury (TBI). |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.